NASDAQ:GILD
Gilead Sciences, Inc.
- Stock
$
industry
Drug Manufacturers / Generalexchange
NASDAQ Global Selectwebsite
www.gilead.comipo date
Jan 01, 1992full time employees
14,400currency
USD
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmon...Show More